Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 466 AL 480

The complexity of Alzheimer's disease: an evolving puzzle

Ferrari C, Sorbi S.

Physiol Rev. 2021 Jul 1;101(3):1047-1081. doi: 10.1152/physrev.00015.2020. Epub 2021 Jan 21.

Advances in Brain Amyloid Imaging

Krishnadas N, Villemagne VL, Doré V, Rowe CC.

Semin Nucl Med. 2021 May;51(3):241-252. doi: 10.1053/j.semnuclmed.2020.12.005. Epub 2021 Jan 19.

The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease

Altiné-Samey R, Antier D, Mavel S, Dufour-Rainfray D, Balageas AC, Beaufils E, Emond P, Foucault-Fruchard L, Chalon S.

Fundam Clin Pharmacol. 2021 Jun;35(3):582-594. doi: 10.1111/fcp.12654. Epub 2021 Mar 8.

Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses

Zhuang QS, Meng L, Wang Z, Shen L, Ji HF.

J Alzheimers Dis. 2021;80(1):271-281. doi: 10.3233/JAD-201235.

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification

Izzo NJ, Yuede CM, LaBarbera KM, Limegrover CS, Rehak C, Yurko R, Waybright L, Look G, Rishton G, Safferstein H, Hamby ME, Williams C, Sadlek K, Edwards HM, Davis CS, Grundman M, Schneider LS, DeKosky ST, Chelsky D, Pike I, Henstridge C, Blennow K, Zetterberg H, LeVine H 3rd, Spires-Jones TL, Cirrito JR, Catalano SM.

Alzheimers Dement. 2021 Aug;17(8):1365-1382. doi: 10.1002/alz.12302. Epub 2021 Feb 8.

Melatonin levels in the Alzheimer's disease continuum: a systematic review

Nous A, Engelborghs S, Smolders I.

Alzheimers Res Ther. 2021 Feb 23;13(1):52. doi: 10.1186/s13195-021-00788-6.

Alzheimer Disease Clinical Trials Targeting Amyloid: Lessons Learned From Success in Mice and Failure in Humans

Reiss AB, Montufar N, DeLeon J, Pinkhasov A, Gomolin IH, Glass AD, Arain HA, Stecker MM.

Neurologist. 2021 Mar 4;26(2):52-61. doi: 10.1097/NRL.0000000000000320.

Alzheimer's disease and its treatment by different approaches: A review

Srivastava S, Ahmad R, Khare SK.

Eur J Med Chem. 2021 Apr 15;216:113320. doi: 10.1016/j.ejmech.2021.113320. Epub 2021 Feb 23.

Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring

van Oostveen WM, de Lange ECM.

Int J Mol Sci. 2021 Feb 20;22(4):2110. doi: 10.3390/ijms22042110.

Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial

Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB, Launer LJ, Detre JA, Wolk DA, Davatzikos C, Williamson JD, Pajewski NM, Bryan RN; SPRINT Research Group.

JAMA Neurol. 2021 May 1;78(5):568-577. doi: 10.1001/jamaneurol.2021.0178.

Therapy for Alzheimer's disease: Missing targets and functional markers?

Stoiljkovic M, Horvath TL, Hajós M.

Ageing Res Rev. 2021 Jul;68:101318. doi: 10.1016/j.arr.2021.101318. Epub 2021 Mar 9.

Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application

Yang J, Jia L, Li Y, Qiu Q, Quan M, Jia J.

J Alzheimers Dis. 2021;81(1):19-32. doi: 10.3233/JAD-201068.

Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease

Buckley RF.

Neurotherapeutics. 2021 Apr;18(2):709-727. doi: 10.1007/s13311-021-01026-5. Epub 2021 Mar 29.

The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer's Disease

Hugon J, Paquet C.

Int J Mol Sci. 2021 Mar 19;22(6):3136. doi: 10.3390/ijms22063136.

Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer's Disease Platform

Karelina T, Lerner S, Stepanov A, Meerson M, Demin O.

CPT Pharmacometrics Syst Pharmacol. 2021 Jun;10(6):543-550. doi: 10.1002/psp4.12628. Epub 2021 May 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias